ES2232143T3 - Preparaciones acuosas semisolidas para administracion por via oral de toltrazuril sulfona. - Google Patents

Preparaciones acuosas semisolidas para administracion por via oral de toltrazuril sulfona.

Info

Publication number
ES2232143T3
ES2232143T3 ES99926343T ES99926343T ES2232143T3 ES 2232143 T3 ES2232143 T3 ES 2232143T3 ES 99926343 T ES99926343 T ES 99926343T ES 99926343 T ES99926343 T ES 99926343T ES 2232143 T3 ES2232143 T3 ES 2232143T3
Authority
ES
Spain
Prior art keywords
weight
concentration
present
toltrazuril
active substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES99926343T
Other languages
English (en)
Spanish (es)
Inventor
Matthias Kuhn
Bettina Rohde
Helmut Schnabel
Hans-Christian Mundt
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer Healthcare AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare AG filed Critical Bayer Healthcare AG
Application granted granted Critical
Publication of ES2232143T3 publication Critical patent/ES2232143T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Glass Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
ES99926343T 1998-06-02 1999-05-20 Preparaciones acuosas semisolidas para administracion por via oral de toltrazuril sulfona. Expired - Lifetime ES2232143T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19824483 1996-06-19
DE19824483A DE19824483A1 (de) 1998-06-02 1998-06-02 Halbfeste wäßrige Zubereitungen für orale Applikation von Toltrazuril-Sulfon

Publications (1)

Publication Number Publication Date
ES2232143T3 true ES2232143T3 (es) 2005-05-16

Family

ID=7869584

Family Applications (1)

Application Number Title Priority Date Filing Date
ES99926343T Expired - Lifetime ES2232143T3 (es) 1998-06-02 1999-05-20 Preparaciones acuosas semisolidas para administracion por via oral de toltrazuril sulfona.

Country Status (18)

Country Link
US (1) US6436935B1 (de)
EP (1) EP1091740B1 (de)
JP (1) JP4958336B2 (de)
KR (1) KR100717832B1 (de)
CN (1) CN1137687C (de)
AT (1) ATE279926T1 (de)
AU (1) AU756372B2 (de)
BR (1) BR9910936B1 (de)
CA (1) CA2333680C (de)
DE (2) DE19824483A1 (de)
DK (1) DK1091740T3 (de)
ES (1) ES2232143T3 (de)
HK (1) HK1038702B (de)
HU (1) HU228500B1 (de)
NZ (1) NZ508513A (de)
PL (1) PL193534B1 (de)
PT (1) PT1091740E (de)
WO (1) WO1999062519A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6150361A (en) * 1998-12-22 2000-11-21 Bayer Corporation Triazineone compounds for treating diseases due to sarcosystis, neospora and toxoplasma
DE10040174A1 (de) 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfonen zur Bekämpfung von Coccidiosen
DE10040110A1 (de) * 2000-08-17 2002-02-28 Bayer Ag Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen
DE102004001558A1 (de) * 2004-01-10 2005-08-18 Bayer Healthcare Ag Arzneimittel zur topischen Applikation bei Tieren
DE102007025908A1 (de) 2007-06-01 2008-12-04 Bayer Healthcare Ag Formulierungen enthaltend Triazinone und Eisen
SI22751A (sl) * 2008-04-03 2009-10-31 Krka, D.D., Novo Mesto Toltrazuril z izboljĺ animi lastnostmi za raztapljanje
DE102009012423A1 (de) 2009-03-10 2010-09-16 Bayer Animal Health Gmbh Zubereitung auf Ölbasis
EP2740470A1 (de) 2012-12-07 2014-06-11 Ceva Sante Animale Behandlung von Coccidiosis mit intramuskulären Triazinzusammensetzungen
EP2740492A1 (de) 2012-12-07 2014-06-11 Ceva Sante Animale Triazinformulierungen, einen weiteren Wirkstoff und Tensid(e) enthaltend
EP2740469A1 (de) 2012-12-07 2014-06-11 Ceva Sante Animale Neue Behandlungen mit Triazinen
EP3578182A1 (de) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulierungen mit triazinonen und eisen mit einem geringen anteil an freien eisenionen
EP3578181A1 (de) 2018-06-05 2019-12-11 Bayer Animal Health GmbH Formulierung zur verwendung bei der gleichzeitigen behandlung von kokzidialen infektionen und eisenmangelzuständen

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2718799A1 (de) * 1977-04-27 1978-11-09 Bayer Ag 1-(4-phenoxy-phenyl)-1,3,5-triazin- derivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel und wachstumsfoerderer
DE3300793A1 (de) * 1983-01-12 1984-07-12 Bayer Ag, 5090 Leverkusen Coccidiosemittel
US4755386A (en) * 1986-01-22 1988-07-05 Schering Corporation Buccal formulation
DE19519821A1 (de) * 1995-05-31 1996-12-05 Bayer Ag Mittel gegen parasitäre Protozoen
DE19603984A1 (de) * 1996-02-05 1997-08-07 Bayer Ag Granulate von Triazinen
US5883095A (en) * 1997-08-07 1999-03-16 University Of Kentucky Research Foundation Formulations and methods to treat and prevent equine protozoal myeloencephalitis
WO1998043644A1 (en) * 1997-03-31 1998-10-08 David Granstrom Formulations and methods to treat and prevent equine protozoal myeloencephalitis

Also Published As

Publication number Publication date
HUP0102007A2 (hu) 2001-11-28
KR100717832B1 (ko) 2007-05-11
AU756372B2 (en) 2003-01-09
KR20010043453A (ko) 2001-05-25
PL344329A1 (en) 2001-10-22
CA2333680C (en) 2009-05-19
US6436935B1 (en) 2002-08-20
HU228500B1 (en) 2013-03-28
JP4958336B2 (ja) 2012-06-20
BR9910936B1 (pt) 2010-11-16
PT1091740E (pt) 2004-12-31
EP1091740A1 (de) 2001-04-18
PL193534B1 (pl) 2007-02-28
HK1038702A1 (en) 2002-03-28
WO1999062519A1 (de) 1999-12-09
DK1091740T3 (da) 2005-01-24
NZ508513A (en) 2002-09-27
HUP0102007A3 (en) 2003-10-28
CN1304310A (zh) 2001-07-18
CA2333680A1 (en) 1999-12-09
EP1091740B1 (de) 2004-10-20
CN1137687C (zh) 2004-02-11
JP2002516862A (ja) 2002-06-11
DE19824483A1 (de) 1999-12-09
AU4364299A (en) 1999-12-20
ATE279926T1 (de) 2004-11-15
BR9910936A (pt) 2001-03-06
HK1038702B (zh) 2004-12-10
DE59910906D1 (de) 2004-11-25

Similar Documents

Publication Publication Date Title
US5772985A (en) Method for treating bovine hairy heel warts
EP2120860B1 (de) Pharamzeutische zusammensetzungen und verfahren zur behandlung von entzündungen bei rindern und anderen tieren
DE60038106T2 (de) Anthelmintische zusammensetzungen
KR100717832B1 (ko) 톨트라주릴 설폰의 경구 투여용 반고체 수성 제제
ES2367584T3 (es) Composiciones concentradas versatiles de alta carga que comprenden metaflumizona para el control de ectoparasitos.
EP0727996B1 (de) Fenbendazolformulierungen
ES2617672T3 (es) Composiciones antihelmínticas de bencimidazol
TWI433691B (zh) 苯并咪唑之非水性組合物
US20080249153A1 (en) Anthelmintic formulations
Knotek Therapeutics and medication
ES2397493T3 (es) Composición líquida autoemulsionable de florfenicol destinada a ser incorporada al agua bebida por el ganado
JP7344641B2 (ja) ビタミン製剤
MXPA00011736A (en) Semi-solid aqueous preparations for oral applications of toltrazuril sulphone
EP2990034A1 (de) Antiseptische tierarzneiformulierung und verfahren zur verwendung davon
ES2316308B1 (es) Medicamento a base de metronidazol y acido azelaico para el tratamiento por via topica de la enfermedad rosacea de mejor asimilacion, y procedimiento de preparacion.
EP1374904A1 (de) Zubereitung enthaltende Polymethylsiloxane für Nagel, Knorpel, Knochengelenk, Muskeln und Sehnen Erkrankungen
ADE the active one
TH78317A (th) สารผสมตามสูตรฆ่าปรสิตเฉพาะที่และวิธีของการรักษา
NZ530286A (en) Anthelmintic formulations containing triclabendazole